SLU-PP-332 30mg — Vial Spec, Reconstitution Math & COA

SLU-PP-332 30mg Overview and Laboratory Target Applications

A 30mg research vial of SLU-PP-332 contains 30 milligrams of highly purified, lyophilized synthetic small-molecule agonist targeted primarily toward Estrogen-Related Receptors (ERRs). Principal investigators and laboratory managers select this 30mg configuration when executing high-throughput cell culture screens, enzyme kinetics assays, or multi-week rodent research protocols requiring consistent, single-lot working stocks.

Because small-molecule metabolic modulators often require repeated dosing or serial dilutions across broad concentration gradients in vitro, purchasing a concentrated 30mg unit minimizes inter-assay variability attributable to lot switching. Researchers studying skeletal muscle remodeling, mitochondrial biogenesis, and cellular respiration rely on SLU-PP-332 to selectively activate the ERRα isoform without engaging classical estrogen receptors (ERα/ERβ).

PX1 Research supplies high-purity research compounds strictly for laboratory research use only. While 30mg represents an ideal high-yield format for larger laboratory workflows, investigators should verify current catalog formats: PX1 maintains an extensive selection of liquid, powder, and oral assay preparations—including specialized solid formats like SLU-PP-332 Capsules 250mcg—to support diverse experimental designs across our complete catalog of all peptides and research compounds.

Reconstitution Mathematics for 30mg SLU-PP-332 Vials

Accurate reconstitution is vital for maintaining target concentration precision across microplate assays and cellular treatments. When preparing a 30mg lyophilized cake of SLU-PP-332, total diluent volume directly dictates final mass concentration (mg/mL and µg/µL). Below are standard volumetric calculations utilized in laboratory environments:

1.0 mL Diluent Addition: Adding 1.0 mL of suitable laboratory solvent yields a final concentration of 30.0 mg/mL (30.0 µg/µL). This high-density stock solution is preferred for preparing highly concentrated DMSO master aliquots intended for subsequent micro-pipetting into culture media.

2.0 mL Diluent Addition: Adding 2.0 mL of solvent yields a working stock of 15.0 mg/mL (15.0 µg/µL). This mid-tier concentration balances volumetric pipetting accuracy with manageable stock storage volumes.

3.0 mL Diluent Addition: Adding 3.0 mL of diluent achieves a concentration of 10.0 mg/mL (10.0 µg/µL). Standardizing to a 10 mg/mL baseline simplifies mental calculations during rapid microplate dosing protocols.

To quickly recalculate custom volumetric dilutions or verify pipette dispense amounts for complex multi-well arrays, technicians should utilize the integrated PX1 reconstitution calculator to prevent mathematical errors in experimental setup.

Solubility Dynamics, Solvents, and Aliquot Planning

SLU-PP-332 displays specific solubility characteristics typical of synthetic pan-ERR agonists. While many small peptides dissolve readily in sterile bacteriostatic water, non-peptidic small molecules like SLU-PP-332 often exhibit hydrophobic properties that require organic co-solvents such as Dimethyl Sulfoxide (DMSO) or Ethanol for initial solubilization, followed by aqueous buffer extension (e.g., Phosphate-Buffered Saline or PEG400/Tween-80 vehicles for in vivo rodent models).

Laboratory personnel preparing a 30mg vial should perform primary solubilization in high-grade, anhydrous DMSO to create a master stock at 10–30 mg/mL. Once fully dissolved, the stock solution should immediately be subdivided into single-use micro-aliquots using polypropylene cryogenic tubes.

Subdividing a 30mg lot into 50 µL or 100 µL working aliquots prevents repeated freeze-thaw cycles, which cause chemical degradation and concentration shift via moisture absorption. Unused working aliquots must be sealed tightly and stored at -80°C to preserve functional molecular stability.

Molecular Mechanism of Action: Target Receptor Biology (ERRα, ERRβ, ERRγ)

SLU-PP-332 was engineered as a potent, synthetic pan-agonist targeting the Estrogen-Related Receptor family, with high functional selectivity for ERRα (as well as ERRβ and ERRγ). Although structurally related to nuclear hormone receptors, ERRs are orphan receptors that do not bind endogenous estrogen; instead, they function as constitutive transcription factors governing cellular energy metabolism.

Preclinical studies suggest that SLU-PP-332 binding activates the transcriptional coactivator PGC-1α (peroxisome proliferator-activated receptor gamma coactivator 1-alpha). This activation cascade upregulates nuclear-encoded mitochondrial genes, driving increased mitochondrial mass, elevated fatty acid oxidation rates, and enhanced basal ATP production in cultured skeletal muscle cells (C2C12 myotubes).

In vitro data indicate that exposure to SLU-PP-332 induces a gene expression profile resembling oxidative muscle transformation (shifting expression toward Type I slow-twitch oxidative fibers). Researchers utilize this compound to map bioenergetic signaling pathways, measure oxygen consumption rates (OCR) via Seahorse extracellular flux analysis, and study metabolic resilience under nutrient deprivation conditions.

Comparative Analysis: SLU-PP-332 vs. Related Bioenergetic Research Compounds

When designing metabolic or metabolic-adaptation research protocols, investigators frequently compare SLU-PP-332 against established bioenergetic research compounds. Understanding the distinct mechanisms of these reference compounds allows researchers to isolate specific transcription pathways.

For example, while SLU-PP-332 operates via direct ERRα/β/γ nuclear receptor activation, compounds like SR9009 target REV-ERBα/β nuclear receptors to regulate circadian rhythms and lipid metabolism. Similarly, the mitochondrial-derived peptide MOTS-c modulates cellular metabolic homeostasis through AMPK activation and nuclear translocation during metabolic stress, rather than acting directly as an ERR pan-agonist. Furthermore, researchers investigating NAD+ kinetics and adipose tissue energy expenditure frequently pair or contrast these agonists with intracellular enzyme inhibitors such as 5-Amino-1MQ, which selectively blocks NNMT activity.

By comparing SLU-PP-332 side-by-side with Rev-Erb agonists, AMPK activators, and NNMT inhibitors, laboratories can comprehensively dissect downstream changes in oxidative phosphorylation, substrate utilization, and mitochondrial density.

Lot-Matched Analytical Verification: HPLC, MS, and COA Standards

Quality assurance is essential when procuring synthetic research compounds for empirical investigation. Substandard purity or presence of uncharacterized synthesis byproducts can confound transcriptomic data, alter enzyme kinetic curves, or induce non-specific cytotoxicity in cell culture models.

Every batch of SLU-PP-332 produced for PX1 Research undergoes rigorous third-party analytical testing in an ISO 17025 accredited laboratory facility. Purity is validated using High-Performance Liquid Chromatography (HPLC) coupled with Mass Spectrometry (MS) to confirm exact molecular mass and ensure a chromatographic purity rating exceeding 98.0%.

In addition to structural identity and purity, PX1 issues lot-specific testing for bacterial endotoxins (LAL assay) to ensure compliance with strict in vitro standards. Laboratory teams can access, download, and review complete raw analytical spectra for their specific lot directly through our centralized COA library.

Storage Parameters and Physical Stability Guidelines

Maintaining chemical integrity over the shelf life of a 30mg SLU-PP-332 vial requires strict adherence to temperature and atmospheric controls:

Lyophilized Powder Storage: Upon receipt, dry lyophilized vials must be stored in a dark, desiccated environment at -20°C for short-to-medium term storage, or at -80°C for extended stability beyond 12 months. Keep vials sealed inside protective packaging to protect against ambient moisture penetration.

Reconstituted Solution Handling: Solubilized liquid stocks (in DMSO or vehicle buffers) should never be stored at room temperature or standard refrigeration (+4°C) for prolonged periods. Reconstituted aliquots stored at -80°C remain stable for research use, provided they are shielded from direct light exposure.

Preventing Degradation: Avoid repeated thermal cycling. Always allow frozen master aliquots to equilibrate to room temperature inside a desiccator before opening to prevent condensate formation inside the vessel.

Selecting the Right Format: 30mg Vials vs. Alternative Research Quantities

Selecting the correct vial size depends entirely on experimental scale, animal cohort size, or microplate throughput requirements. A 30mg vial is designed primarily for high-demand research settings, such as multi-animal in vivo preclinical studies or long-term cell line passage series where maintaining a single lot identifier across all control and variable groups is vital.

For smaller exploratory assays, pilot studies, or initial single-well concentration curves, smaller unit sizes may be preferred to eliminate excess reconstituted material. Conversely, large institutional projects or screening facilities requiring bulk quantities can access scalable supply chains and customized fill options through our specialized PX1 wholesale program.

Regardless of the format selected—whether custom raw material, small-volume vials, or solid oral assay formats—PX1 Research guarantees USA-manufactured quality, identical batch-to-batch consistency, and complete analytical transparency via our online research hub.